SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-003343
Filing Date
2017-05-11
Accepted
2017-05-11 09:14:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2232112z424b5.htm 424B5 211908
2 G249818.JPG g249818.jpg GRAPHIC 8049
3 G805648.JPG g805648.jpg GRAPHIC 11910
  Complete submission text file 0001047469-17-003343.txt   240730
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214409 | Film No.: 17832695
SIC: 2834 Pharmaceutical Preparations